Company intelligence / Profile preview

Ace Therapeutics

Ownership
Private
Development stage
Other
01

Overview

Ace Therapeutics is a service provider specializing in preclinical modeling for metabolic, autoimmune, neurological, and ophthalmic indications; does not advance its own drug assets but enables pharmaceutical and biotech R&D through validated models and assays

Therapeutic areas
NeurologyEndocrinologyDermatologyOphthalmology
Modalities
Small moleculeBiologicPeptidesMonoclonal antibody
Industry
Drug Discovery Services
02

Partnerships

Service partner for global pharmaceutical and biotechnology companies

Beyond the preview

Go deeper on Ace Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ace Therapeutics.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call